Goldentree Asset Management LP Bausch Health Companies Inc. Transaction History

Goldentree Asset Management LP

$1.32 Billion
Q4 2024

A detailed history of Goldentree Asset Management LP transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Goldentree Asset Management LP holds 27,540,075 shares of BHC stock, worth $193 Million. This represents 16.77% of its overall portfolio holdings.

Number of Shares

27,540,075

Previous 29,395,745 6.31%

Holding current value

$193 Million

Previous $240 Million 7.35%

% of portfolio

16.77%

Previous 21.8%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$7.34 - $9.78 $13.6 Million - $18.1 Million	-1,855,670 Reduced 6.31%	27,540,075 $222 Million
Q3 2024 Nov 14, 2024	BUY	$5.22 - $8.26 $36.3 Million - $57.5 Million	6,958,717 Added 31.01%	29,395,745 $240 Million
Q2 2024 Aug 14, 2024	SELL	$6.1 - $10.41 $31.8 Million - $54.2 Million	-5,207,931 Reduced 18.84%	22,437,028 $156 Million
Q4 2023 Feb 14, 2024	BUY	$6.53 - $8.23 $23.9 Million - $30.1 Million	3,657,497 Added 15.25%	27,644,959 $222 Million
Q3 2023 Nov 13, 2023	BUY	$7.69 - $9.71 $30.2 Million - $38.2 Million	3,931,234 Added 19.6%	23,987,462 $197 Million
Q2 2023 Aug 09, 2023	BUY	$5.72 - $8.8 $20.2 Million - $31 Million	3,523,230 Added 21.31%	20,056,228 $160 Million
Q1 2023 May 11, 2023	SELL	$6.28 - $9.85 $29.8 Million - $46.8 Million	-4,750,711 Reduced 22.32%	16,532,998 $134 Million
Q4 2022 Feb 14, 2023	BUY	$6.09 - $7.93 $29.2 Million - $38.1 Million	4,798,327 Added 29.11%	21,283,709 $134 Million
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $11 Million - $22.2 Million	2,411,917 Added 17.14%	16,485,382 $114 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $43.1 Million - $144 Million	6,099,491 Added 76.49%	14,073,465 $118 Million
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $43.8 Million - $56.3 Million	2,026,355 Added 34.07%	7,973,974 $182 Million
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $78.1 Million - $98.5 Million	-3,394,999 Reduced 36.34%	5,947,619 $164 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $29.4 Million - $35.3 Million	1,175,857 Added 14.4%	9,342,618 $260 Million
Q2 2021 Aug 13, 2021	SELL	$27.43 - $32.7 $11.6 Million - $13.8 Million	-421,531 Reduced 4.91%	8,166,761 $239 Million
Q1 2021 May 14, 2021	SELL	$21.37 - $34.38 $55.6 Million - $89.5 Million	-2,603,061 Reduced 23.26%	8,588,292 $273 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $62.2 Million - $85.8 Million	4,062,113 Added 56.98%	11,191,353 $233 Million
Q3 2020 Nov 13, 2020	SELL	$14.88 - $20.13 $10.9 Million - $14.7 Million	-730,224 Reduced 9.29%	7,129,240 $111 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $10.4 Million - $16.1 Million	-785,043 Reduced 9.08%	7,859,464 $144 Million
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $19.2 Million - $44.8 Million	1,480,131 Added 20.66%	8,644,507 $134 Million
Q4 2019 Feb 13, 2020	BUY	$18.89 - $31.89 $6.93 Million - $11.7 Million	367,000 Added 5.4%	7,164,376 $214 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $21.4 Million - $26.3 Million	-1,025,215 Reduced 13.11%	6,797,376 $149 Million
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $61.9 Million - $79.8 Million	3,018,574 Added 62.83%	7,822,591 $197 Million
Q1 2019 May 15, 2019	BUY	$20.23 - $26.29 $12.8 Million - $16.6 Million	631,800 Added 15.14%	4,804,017 $119 Million
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $25.9 Million - $41.7 Million	1,470,919 Added 54.45%	4,172,217 $77.1 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $55.8 Million - $69.3 Million	2,701,298 New	2,701,298 $69.3 Million

Others Institutions Holding BHC

# of Institutions

271

Shares Held

252M

Call Options Held

5.12M

Put Options Held

9.43M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.54B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldentree Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Goldentree Asset Management LP with notifications on news.

Account

Goldentree Asset Management LP Bausch Health Companies Inc. Transaction History